Warner Bros. Discovery, Inc.
CYCLOPROPYLAMINE COMPOUND AS LSD1 INHIBITOR AND USE THEREOF
Last updated:
Abstract:
Provided is a cyclopropylamine compound as lysine-specific demethylase 1 (LSD1) inhibitor, and a use thereof in preparation of drug for treating diseases associated with LSD1. The cyclopropylamine compound is a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
12 Sep 2019
Issue date:
21 Apr 2022